Trifluoromethanesulfonic Acid

Trifluoromethanesulfonic Acid

SCHEMBL2331987

Nc1ccccc1.O=S(=O)(O)C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.50
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
CA5A P35218 2/20 0.43
CA9 Q16790 2/20 0.43
ALDH1A1 P00352 4/20 0.43
NT5E P21589 1/20 0.43
TDP1 Q9NUW8 3/20 0.42
HSD17B10 Q99714 2/20 0.42
PTPN1 P18031 2/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
KMT2A Q03164 2/20 0.38
KEAP1 Q14145 1/20 0.38
LMNA P02545 3/20 0.38
MEN1 O00255 1/20 0.38
CYP3A4 P08684 2/20 0.37
TAAR1 Q96RJ0 1/20 0.37
CES1 P23141 1/20 0.37
PBRM1 Q86U86 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL28080412 0.98 TSHR (0.48) TSHRCA1CA2CA5ACA9
Aniline SCHEMBL11772251 0.83 TSHR (0.58) TSHRCA1CA2CA5ACA9
Aniline SCHEMBL167326 0.83 TSHR (0.65) TSHRCA1CA2CA5ACA9
Aniline SCHEMBL167327 0.83 TSHR (0.65) TSHRCA1CA2CA5ACA9
Aniline SCHEMBL676147 0.83 TSHR (0.65) TSHRCA1CA2CA5ACA9
Biphenyl SCHEMBL1050411 0.81 PTPN1 (0.58) TSHRCA1CA2CA5ACA9
Aniline SCHEMBL28037884 0.80 TSHR (0.61) TSHRCA1CA2CA5ACA9
Aniline SCHEMBL5693986 0.80 TSHR (0.61) TSHRCA1CA2CA5ACA9
Aniline SCHEMBL3156113 0.80 TSHR (0.61) TSHRCA1CA2CA5ACA9
Trifluoromethanesulfonic Acid SCHEMBL30552135 0.80 ALDH1A1 (0.50) TSHRCA1CA2CA5ACA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116134108-A Room temperature stable conductive 1K epoxy formulations 汉高股份有限及两合公司 2023-05-16 CN claimed
CN-114540848-A Decarboxylation coupling electrocatalysis method for realizing catalysis of aromatic trimethyl ammonium salt and alpha-nickel keto acid 常州工学院 2022-05-27 CN claimed
CN-122039179-A Poly (N-phenylaniline) triflate and preparation, electrode plate and battery thereof 中国石油大学(华东) 2026-05-15 CN disclosed
US-20250041223-A1 LIPOSOME LOADING PLUMB PHARMACEUTICALS, INC. 2025-02-06 US disclosed
WO-2024185458-A1 RESIN COMPOSITION, CURED FILM, METHOD FOR PRODUCING SUBSTRATE WITH PATTERN OF CURED FILM, OPTICAL ELEMENT, AND METHOD FOR PRODUCING POLYSILOXANE 東レ株式会社 2024-09-12 WO disclosed
US-12059499-B2 Liposome loading PLUMB PHARMACEUTICALS, INC. (US) 2024-08-13 US disclosed
CN-114540848-B Decarboxylation coupling electrocatalytic method for realizing catalysis of aromatic trimethylammonium salt and alpha-nickel ketoacid 常州工学院 2023-09-01 CN disclosed
EP-4212148-A1 LIPOSOME LOADING Plumb Pharmaceuticals, Inc. (US) 2023-07-19 EP disclosed
CN-116134108-A Room temperature stable conductive 1K epoxy formulations 汉高股份有限及两合公司 2023-05-16 CN disclosed
EP-3388435-B1 PYRROLOBENZODIAZEPINES AND TARGETED CONJUGATES SEAGEN INC (US) 2023-05-03 EP disclosed
EP-3302435-B1 LIPOSOME LOADING PLUMB PHARMACEUTICALS INC (US) 2023-03-08 EP disclosed
CN-103987384-A Pyrrolobenzodiazepines and targeting conjugates SEATTLE GENETICS INC 2014-08-13 CN disclosed
EP-2164590-B1 METHOD FOR THE DIRECT ELUTION OF REACTIVE 18F FLUORIDE FROM AN ANION EXCHANGE RESIN IN AN ORGANIC MEDIUM SUITABLE FOR RADIOLABELLING WITHOUT ANY EVAPORATION STEP BY THE USE OF STRONG ORGANIC BASES TRASIS S A (BE) 2013-03-06 EP disclosed
US-8002851-B2 Thermochromic ink and coating compositions NBCUNIVERSAL MEDIA LLC (US) 2011-08-23 US disclosed
US-20100234504-A1 THERMOCHROMIC INK AND COATING COMPOSITIONS GENERAL ELECTRIC COMPANY (US) 2010-09-16 US disclosed
US-7250523-B2 Imido-tethered carbenes of molybdenum for ring-opening metathesis polymerization and ring-closing metathesis BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2007-07-31 US disclosed
US-20050101475-A1 Imido-tethered carbenes of molybdenum for ring-opening metathesis polymerization and ring-closing metathesis BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) 2005-05-12 US disclosed
EP-0563289-A1 METHOD OF PROCESSING ELECTRICALLY CONDUCTIVE POLYANILINES IN SOLVENT MIXTURES AlliedSignal Inc. (US) 1993-10-06 EP disclosed
WO-1992011644-A1 METHOD OF PROCESSING ELECTRICALLY CONDUCTIVE POLYANILINES IN SOLVENT MIXTURES ALLIED-SIGNAL INC. (US) 1992-07-09 WO disclosed
US-5059711-A PROCESS FOR THE PREPARATION OF TRIFLUOROMETHANESULPHONIC ACID BAYER AKTIENGESELLSCHAFT (DE) 1991-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050101475-A1 Imido-tethered carbenes of molybdenum for ring-opening metathesis polymerization and ring-closing metathesis NOXO1, PPOX, CBR1 TSHR 2143/4885CA1 3279/4885CA2 2638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.